Abstract:Objective: Recent evidence suggests that disturbances of sleep architecture are linked to Alzheimer's disease (AD) pathology. Here, we assessed the association between sleep architecture and regional amyloid and tau pathology employing a portable sleep-monitoring device in addition to PET imaging. Methods: 18 cognitively normal adults (CN; M(Age) = 64.06 (8.63), Sex (M/F) =6/12) and 18 patients with MCI/early AD (M(Age) = 67.33 (8.25), Sex (M/F) =9/9) were included from the 'Tau Propagation Over Time' (T-POT) study. All subjects underwent amyloid ([11C]-PiB) and tau ([18F]-AV1451) PET imaging. PET images were normalized to MNI-space and intensity standardized to the whole cerebellum ([11C]-PiB) or the inferior cerebellum ([18F]-AV1451). Sleep monitoring was performed at home using the portable 'Dreem' EEG-headband (Beacon Biosignal), which is a reliable and comfortable wireless alternative to the gold-standard polysomnography (PSG). Sleep recordings were performed within six months of the PET acquisitions. At least, one sufficient night had to be acquired, which was used to assess the sleep macrostructure for each individual. Total duration of sleep phases per minutes (i.e. REM, N1, N2, N3) and total sleep time were extracted. In a first step, a linear mixed model (LMM) was used to compare the groups in terms of duration of the different sleep stages across the nightly recordings. Given the results of this comparison, mean N1 and N3 duration were subsequently correlated with regional amyloid and tau pathology SUVRs of 34 cortical regions using Spearman's correlation. The reported results are based on one-tailed tests. All analyses were corrected for age. Results: Patients with MCI/AD showed reduced N3 duration (p = .007) compared to the CN group. A trend was observed indicating that patients with MCI/AD exhibited longer N1 durations (p = .094); however, this difference did not reach statistical significance. Shorter N3 duration was associated with higher regional amyloid load in the paracentral lobe and the posterior cingulate gyrus, whereas longer N1 duration was linked to higher amyloid pathology in several regions, including the medial temporal lobe, cingulate cortex and the occipital lobe. Moreover, associations were observed between longer N1 duration and greater tau burden in regions comprising the temporal lobe, cingulate cortex, and medial-frontal areas of the brain. Conclusion: Differences in sleep architecture between healthy controls and MCI/AD may arise from regionally-specific accumulation patterns of AD pathologies. Although it remains unknown whether disruptions in sleep architecture are a cause or a consequence, a complex relationship between AD-aggregation pathology in specific brain regions and the different phases of sleep appears to emerge.

NREM delta power and AD-relevant tauopathy are associated with shared cortical gene networks

Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration

Reduced synchrony in alpha oscillations during life predicts post mortem neurofibrillary tangle density in early‐onset and atypical Alzheimer's disease

Neuronal Levels and Sequence of Tau Modulate the Power of Brain Rhythms

Amyloid beta-independent sleep markers associated with early regional tau burden and cortical thinning

Sleep Disruption Precedes Forebrain Synaptic Tau Burden and Contributes to Cognitive Decline in a Sex-Dependent Manner in the P301S Tau Transgenic Mouse Model

Decreased Orexin Receptor 1 mRNA Expression in the Locus Coeruleus in Both Tau Transgenic rTg4510 and Tau Knockout Mice and Accompanying Ascending Arousal System Tau Invasion in rTg4510

Associations between the multitrajectory neuroplasticity of neuronavigated rTMS‐mediated angular gyrus networks and brain gene expression in AD spectrum patients with sleep disorders

Early-stage dysfunction of hippocampal theta and gamma oscillations and its modulation of neural network in a transgenic 5xFAD mouse model

Regional associations of sleep architecture and Alzheimer's disease pathology

Early Changes in Alpha Band Power and DMN BOLD Activity in Alzheimer’s Disease: A Simultaneous Resting State EEG-fMRI Study

Sleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer's disease with plaques and tangles

Consequences of Pathogenic Tau Expression in Mouse Locus Coeruleus

The wake- and sleep-modulating neurons of the lateral hypothalamic area demonstrate a differential pattern of degeneration in Alzheimers disease

Meta-Analysis in Transgenic Alzheimer's Disease Mouse Models Reveals Opposite Brain Network Effects of Amyloid-β and Phosphorylated Tau Proteins

Data from single nuclei RNA‐sequencing reveals a prodromal gene network response in excitatory neurons of a humanized rat Alzheimer’s disease model

Disruption of sleep macro- and microstructure in Alzheimer’s disease: overlaps between neuropsychology, neurophysiology, and neuroimaging

Deep multilayer brain proteomics identifies molecular networks and Netrin‐1 accumulation in Alzheimer’s disease progression: Genetics/omics and systems biology

Integrative Network Analysis of Nineteen Brain Regions Identifies Molecular Signatures and Networks Underlying Selective Regional Vulnerability to Alzheimer’s Disease

Selective vulnerability and resilience to Alzheimer’s disease tauopathy as a function of genes and the connectome

Sleep and Alzheimer’s Disease: Shared Genetic Risk Factors, Drug Targets, Molecular Mechanisms, and Causal Effects